Stem cell research: cutting-edge science or corporate subsidies, courtesy of voters?
By Capitol Weekly,
Capitol Weekly
| 09. 15. 2005
[Quotes CGS's Marcy Darnovsky]
The organizations created to fund stem cell research in California announced
their first grants last week, despite the fact that the money is held up in
lawsuits. But are they rushing to further science or escape politics?
Last fall, voters approved a stem cell initiative, Proposition 71, by a
59-41 percent margin. Ten months later, the $3 billion in bonds voters
approved are tied up in lawsuits by Republican and anti-abortion groups who
oppose embryonic stem cell research.
Yet, in the long-run, the organizations created by Prop. 71--the Independent
Citizen_s Oversight Committee and the California Institute for Regenerative
Medicine--may have more to worry about from their original allies. A
coalition of Democratic skeptics has put forth a message more likely to gain
traction: You can support stem cell research and still oppose the results of
Prop. 71.
"The debate was framed as being a referendum on stem cell research and
whether you support President Bush," said Jesse Reynolds of the Center for
Genetics and Society. "California voters didn_t approve this as a corporate
subsidy."
Reynolds_ message has gotten support in...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...